Medtronic

4 Stocks for Our Dads on Father's Day

In May, we presented our moms with stock picks they'd appreciate. Now, for Father's Day, we've had four of our writers pick out some stocks to perk up their dads' portfolios.

2012 Election: Which Industries Won When Obama Did

The election is over, and now, the many investors who were keeping a close eye on the polls know what they're getting (somewhat) in terms of the federal government for the next few years. Here's a look at 21 economic sectors, and what a second Obama term will mean for each of them.

10 Best Stock Picks of the 10 Richest Hedge Funds

The smartest money on Wall Street may be at the top hedge funds, whose investment managers are paid billions a year to beat the market. Those gurus only take big money clients, but you can follow their lead: DailyFinance has the 10 best stock picks of the 10 highest-paid hedge fund managers.

Four Cash-Rich Pharma Picks From Goldman

While a new report from Goldman says health care is in a state of flux that most of the sector's companies haven't adjusted to yet, it also pinpoints four that have plenty of cash that could be put to good use for investors.

FDA Eyes Overhaul of Medical Device Regulation

The Food and Drug Administration is proposing to revamp its regulations of medical devices, the agency said Wednesday. While seeking to improve device safety, the FDA also wants to ease the regulatory environment and foster innovation. But the proposals have the industry concerned.

Drug Approval Lifts Novo Nordisk, Amylin Stock

Federal regulators approved Novo Nordisk's new once-daily injection for treating Type 2 diabetes Victoza, driving shares higher. Shares of Amylin Pharmaceuticals also rallied as the approval of Victoza raises hopes that Amylin's rival drug will also get the greenlight.

Health-Care Sector Appears to Rally As Reform Chances Dim

President Obama can't be pleased by the loss of a Democratic Senate seat which jeopardizes passage of his cherished health-care reform. The news, however, appears to have fueled a mini stock rally in the health-care and pharma sectors wary of how any reform would affect their businesses. The uptrend is expected to continue.